| Computational chemistry and molecular modeling: principles and applications KI Ramachandran, G Deepa, K Namboori Springer Science & Business Media, 2008 | 570 | 2008 |
| The ApoE gene of Alzheimer's disease (AD) PKK Namboori, KV Vineeth, V Rohith, I Hassan, L Sekhar, A Sekhar, ... Functional & integrative genomics 11, 519-522, 2011 | 45 | 2011 |
| Krishnan,“ A Iyer, A Vyshnavi, M Hima, PK Namboori Deep Convolution Network-Based Prediction Model For Medical Diagnosis Of …, 2018 | 43 | 2018 |
| Detection of multi-class retinal diseases using artificial intelligence: an expeditious learning using deep CNN with minimal data S Karthikeyan, KP Sanjay, RJ Madhusudan, SK Sundaramoorthy, ... Biomedical & Pharmacology Journal 12 (3), 1577, 2019 | 38 | 2019 |
| Healthcare security using blockchain for pharmacogenomics M Abraham, AMH Vyshnavi, C Srinivasan, PKK Namboori Journal of International Pharmaceutical Research 46 (1), 529-533, 2019 | 23 | 2019 |
| Targeting a conserved pocket (n-octyl-β-D–glucoside) on the dengue virus envelope protein by small bioactive molecule inhibitors KNPKSJ P. Naresh,A. Selvaraj,P. Shyam Sundar,S. MurugesanORCID Icon,S ... Journal of Biomolecular Structure and Dynamics, DOI: 10.1080/07391102.2020 …, 2020 | 19* | 2020 |
| Evaluation of colorectal cancer (CRC) epidemiology a pharmacogenomic approach AM HimaVyshnavi, OM Deepak, PKK Namboori Journal of Young Pharmacists 9 (1), 36, 2017 | 17 | 2017 |
| ‘BRCA1’ RESPONSIVENESS TOWARDS BREAST CANCER-A POPULATION-WISE PHARMACOGENOMIC ANALYSIS PKKN Preethi M. Iyer, Sanjay Kumar P., Karthikeyan S. International Journal of Pharmacy and Pharmaceutical Sciences 8 (9), 266-270, 2016 | 17* | 2016 |
| Comprehensive strategy for the design of precision drugs and identification of genetic signature behind proneness of the disease—a pharmacogenomic approach PM Iyer, S Karthikeyan, P Sanjay Kumar, PK Krishnan Namboori Functional & integrative genomics 17, 375-385, 2017 | 14 | 2017 |
| Leveraging decagonal in-silico strategies for uncovering IL-6 inhibitors with precision AK Swaroop, PKK Namboori, M Esakkimuthukumar, TK Praveen, ... Computers in Biology and Medicine 163, 107231, 2023 | 10 | 2023 |
| Evaluation of kaempferol as AKT dependent mTOR regulator via targeting FKBP-12 in hepatocellular carcinoma: an in silico approach P Siniprasad, B Nair, V Balasubramaniam, P Sadanandan, PK Namboori, ... Letters in Drug Design & Discovery 17 (11), 1401-1408, 2020 | 10 | 2020 |
| Design and development of potential flavonoid moiety for PBP2a inhibition for MRSA therapy-a computational technique M Sangeetha, TS Saranya, S Sathianarayanan, HV AM, PKK Namboori Biomedical and Pharmacology Journal 13 (2), 687-692, 2020 | 10 | 2020 |
| Deep convolution network based prediction model for medical diagnosis of lung cancer-a deep pharmacogenomic approach: Deep diagnosis for Lung Cancer A Iyer, HV AM, KN PK 2018 Second international conference on advances in electronics, computers …, 2018 | 10 | 2018 |
| Computational Chemistry and Molecular Modeling K Ramachandra, G Deepa, K Namboori Springer: Berlin, 2008 | 10 | 2008 |
| Thyroid cancer prediction using gene expression profile, pharmacogenomic variants and quantum image processing in deep learning platform-a theranostic approach V Sajeev, AMH Vyshnavi, PKK Namboori 2020 International Conference for Emerging Technology (INCET), 1-5, 2020 | 9 | 2020 |
| Tumor hypoxia Diagnosis using deep CNN learning strategy a theranostic pharmacogenomic approach B Vaisali, CR Parvathy, HV AM, KN PK International Journal of Prognostics and Health Management 10 (3), 2019 | 9 | 2019 |
| Prediction of epigenetic variations in Alzheimer's disease-identification of ethnic variants through pharmacogenomic approach PMIPKKN Sanjaykumar P, S Karthikeyan Research Journal of Pharmaceutical, biological and chemical sciences 7 (4 …, 2016 | 9 | 2016 |
| Insilico Analysis of Nano Polyamidoamine (PAMAM) Dendrimers for Cancer Drug Delivery R Radhika, V Rohith, NC Anil Kumar, K Varun Gopal, ... Int. J. Recent Trends Eng. Technol 4, 142-144, 2010 | 7 | 2010 |
| Identification of (2R,3R)-2-(3,4-dihydroxyphenyl)chroman-3-yl-3,4,5-trihydroxy benzoate as multiple inhibitors of SARS-CoV-2 targets; a systematic molecular modelling approach. KNPKSKM Jubie Selvaraj,Shyam Sundar P,Logesh Rajan,Divakar Selvaraj,Dhanabal ... RSC Advances 11, 13051-13060, 2021 | 6 | 2021 |
| Individual variation in p53 responsiveness:a pharmacogenomic approach AGNKNPK Anusooya N J, Krishnapriya A S, Deepak O M World journal of Pharmacy and pharmaceutical sciences 3 (2), 2059-2069, 2014 | 6 | 2014 |
Ramachandran K IProfessor, Centre for Computational Engineering & Networking, Amrita Vishwa VidyapeethamVerified email at cb.amrita.edu
